Proteome analysis reveals candidate markers of disease progression in amyotrophic lateral sclerosis (ALS)

Neuroscience Letters

Volumn 468, Issue 1, 2010, Pages 23-27

  Brettschneider, Johannes ^a   Lehmensiek, Vera ^a   Mogel, Helga ^a   Pfeifle, Martin ^a   Dorst, Johannes ^a   Hendrich, Corinna ^a   Ludolph, Albert C ^a   Tumani, Hayrettin ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

2 D DIGE; Amyotrophic lateral sclerosis; Cerebrospinal fluid; Progression of disease; Proteomics

Indexed keywords

ALPHA 1 ANTITRYPSIN; FETUIN A; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 1; ISOPROTEIN; NEBULIN; PREALBUMIN; PROTEIN DERIVATIVE; PROTEIN PRECURSOR; PROTEOME; RILUZOLE; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; UPREGULATION;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEOME; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 70449529300     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.10.053     Document Type: Article

References (28)

1. Beghi E., Logroscino G., Chio A., Hardiman O., Mitchell D., Swingler R., and Traynor B.J. The epidemiology of ALS and the role of population-based registries. Biochim. Biophys. Acta 1762 (2006) 1150-1157
2. Brettschneider J., Mogel H., Lehmensiek V., Ahlert T., Sussmuth S., Ludolph A.C., and Tumani H. Proteome analysis of cerebrospinal fluid in amyotrophic lateral sclerosis (ALS). Neurochem. Res. 33 (2008) 2358-2363
3. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 (2000) 293-299
4. Duan W., and Schreiber G. Expression of retinol-binding protein mRNA in mammalian choroid plexus. Comp. Biochem. Physiol. B 101 (1992) 399-406
5. Fischer L.R., and Glass J.D. Axonal degeneration in motor neuron disease. Neurodegener. Dis. 4 (2007) 431-442
6. Fleming C.E., Saraiva M.J., and Sousa M.M. Transthyretin enhances nerve regeneration. J. Neurochem. 103 (2007) 831-839
7. Freeman W.M., and Hemby S.E. Proteomics for protein expression profiling in neuroscience. Neurochem. Res. 29 (2004) 1065-1081
8. Heiss A., Eckert T., Aretz A., Richtering W., van Dorp W., Schafer C., and Jahnen-Dechent W. Hierarchical role of fetuin-A and acidic serum proteins in the formation and stabilization of calcium phosphate particles. J. Biol. Chem. 283 (2008) 14815-14825
9. Kleyweg R.P., van der Meche F.G., and Schmitz P.I. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve 14 (1991) 1103-1109
10. Lebreton J.P., Joisel F., Raoult J.P., Lannuzel B., Rogez J.P., and Humbert G. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J. Clin. Invest. 64 (1979) 1118-1129
11. Lehmensiek V., Sussmuth S.D., Brettschneider J., Tauscher G., Felk S., Gillardon F., and Tumani H. Proteome analysis of cerebrospinal fluid in Guillain-Barre syndrome (GBS). J. Neuroimmunol. 185 (2007) 190-194
12. Lehmensiek V., Sussmuth S.D., Tauscher G., Brettschneider J., Felk S., Gillardon F., and Tumani H. Cerebrospinal fluid proteome profile in multiple sclerosis. Multi. Scler. 13 (2007) 840-849
13. Leigh P.N., Abrahams S., Al-Chalabi A., Ampong M.A., Goldstein L.H., Johnson J., Lyall R., Moxham J., Mustfa N., Rio A., Shaw C., and Willey E. The management of motor neurone disease. J. Neurol. Neurosurg. Psychiatry 74 Suppl. 4 (2003) iv32-iv47
14. Liz M.A., Fleming C.E., Nunes A.F., Almeida M.R., Mar F.M., Choe Y., Craik C.S., Powers J.C., Bogyo M., and Sousa M.M. Substrate specificity of transthyretin: identification of natural substrates in the nervous system. Biochem. J. (2009)
15. Marouga R., David S., and Hawkins E. The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal. Bioanal. Chem. 382 (2005) 669-678
16. Murakami T., Ohsawa Y., and Sunada Y. The transthyretin gene is expressed in human and rodent dorsal root ganglia. Neurosci. Lett. 436 (2008) 335-339
17. Nunes A.F., and Sousa M.M. Transthyretin knockout mouse nerves have increased lipoprotein lipase and sphingolipid content following crush. Neurosci. Lett. 446 (2008) 83-87
18. Ranganathan S., Williams E., Ganchev P., Gopalakrishnan V., Lacomis D., Urbinelli L., Newhall K., Cudkowicz M.E., Brown Jr. R.H., and Bowser R. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J. Neurochem. 95 (2005) 1461-1471
19. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310 (2001) 173-186
20. Strong M., and Rosenfeld J. Amyotrophic lateral sclerosis: a review of current concepts. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4 (2003) 136-143
21. Sussmuth S.D., Brettschneider J., Ludolph A.C., and Tumani H. Biochemical markers in CSF of ALS patients. Curr. Med. Chem. 15 (2008) 1788-1801
22. Szweras M., Liu D., Partridge E.A., Pawling J., Sukhu B., Clokie C., Jahnen-Dechent W., Tenenbaum H.C., Swallow C.J., Grynpas M.D., and Dennis J.W. Alpha 2-HS glycoprotein/fetuin, a transforming growth factor-beta/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling. J. Biol. Chem. 277 (2002) 19991-19997
23. Tumani H., Lehmensiek V., Rau D., Guttmann I., Tauscher G., Mogel H., Palm C., Hirt V., Suessmuth S.D., Sapunova-Meier I., Ludolph A.C., and Brettschneider J. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neurosci. Lett. 452 (2009) 214-217
24. Tumani H., Teunissen C., Sussmuth S., Otto M., Ludolph A.C., and Brettschneider J. Cerebrospinal fluid biomarkers of neurodegeneration in chronic neurological diseases. Expert Rev. Mol. Diagn. 8 (2008) 479-494
25. Turner M.R., Kiernan M.C., Leigh P.N., and Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 8 (2009) 94-109
26. Westermeier R., and Marouga R. Protein detection methods in proteomics research. Biosci. Rep. 25 (2005) 19-32
27. Weydt P., Yuen E.C., Ransom B.R., and Moller T. Increased cytotoxic potential of microglia from ALS-transgenic mice. Glia 48 (2004) 179-182
28. Winhammar J.M., Rowe D.B., Henderson R.D., and Kiernan M.C. Assessment of disease progression in motor neuron disease. Lancet Neurol. 4 (2005) 229-238